SpyGlass Pharma, Inc.
SGPNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for SGP. That does not mean none is planned.
Get an email about SGP's next catalysts
Track SpyGlass Pharma (SGP) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 1 past
No catalysts found.
Market Overview
Stock performance and key metrics
Bimatoprost Implant System
Cataract
Timolol Maleate Ophthalmic
Cataract
Bimatoprost Implant System (High Dose)
Cataract
Bimatoprost Implant System (Low Dose)
Cataract
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Bimatoprost Implant System | Phase 3 | Cataract | - | - |
Timolol Maleate Ophthalmic | Phase 3 | Cataract | - | - |
Bimatoprost Implant System (High Dose) | Phase 2 | Cataract | - | - |
Bimatoprost Implant System (Low Dose) | Phase 2 | Cataract | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in SpyGlass Pharma, Inc.'s drug pipeline?→
CatalystAlert tracks 4 drug candidates in SpyGlass Pharma, Inc.'s (SGP) pipeline across Phase 3, Phase 2. Its lead program is Bimatoprost Implant System (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is SpyGlass Pharma, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for SpyGlass Pharma, Inc. (SGP) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track SGP biotech catalysts?→
Add SGP to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow SpyGlass Pharma, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.